Correlation between Glomerular Infiltration Rate and Left Ventricular Mass Index in Chronic Kidney Disease Patients

Authors

  • Kesinee Leedumrongwattanakul Pranangklao Hospital, Faculty of Medicine, Siam University
  • Apisit Leedumrongwattanakul Pranangklao Hospital, Faculty of Medicine, Siam University

Keywords:

Chronic kidney disease, Left ventricular mass index

Abstract

Background: Chronic kidney disease induced increases in left ventricular mass index were found to correlate with glomerular filtration rate. The relationship and risk factors of cardiac structure and glomerular filtration rate have not been studied in Thai patients. Objectives: This study was to investigate the correlation between glomerular filtration rate (GFR) and left ventricular mass index in chronic kidney disease (CKD) Thai patients. Methods: This cross-sectional study was conducted at Pranangklao Hospital between January 2016 and December 2021. A total of 248 CKD patients were included in the study. The mean age of the patients was 64.18±14.57 years, and 37.1% of the patients were male. The mean glomerular infiltration rate (GFR) was 57.63±34.22 ml/min/1.73m2, and the mean LVMI was 113.31±41 g/m2. The majority of the patients had hypertension and dyslipidemia and were being treated with statins and beta blockers. Results: Left ventricular mass index (LVMI) was negatively correlated with hematocrit (r = -0.147, p = .02) and GFR (r = -0.283, p < .001) and positively correlated with hypertension (r = 0.228, p < .001), diabetes mellitus (r = 0.173, p = .006), dyslipidemia (r = 0.24, p < .001), coronary artery disease (r = 0.216, p = .001), LVMI (r = 0.947, p < .001), relative wall thickness (r = 0.205, p = .001), left atrial volume index (r = 0.557, p < .001), right atrial pressure (r = 0.161, p = .011), tricuspid regurgitation velocity (r = 0.214, p = .001), right ventricular systolic pressure (r = 0.306, p < .001), and mean pulmonary artery pressure (r = 0.344, p < .001). Conclusion: This study found a significant correlation between GFR and LVMI in Thai CKD patients (r = -0.283). The results suggest that as GFR declines, LVMI increases, which may lead to adverse cardiovascular outcomes.

References

McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109(8):1004-9.

Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003;41(8):1364-72.

Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113(5):671-8.

Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375(9731):2073-81.

Gori M, Senni M, Gupta DK, Charytan DM, KraigherKrainer E, Pieske B, et al. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J 2014;35(48):3442-51.

Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34(1):125-34.

Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, et al. NT-proBNP and echocardio graphic parameters for prediction of cardiovascular outcomes in patients with CKD stages G2-G4. Clin J Am Soc Nephrol 2016;11(11):1978-88.

Nishio M, Sakata Y, Mano T, Ohtani T, Takeda Y, Hori M, et al. Difference of clinical characteristics between hypertensive patients with and without diastolic heart failure: the roles of diastolic dysfunction and renal insufficiency. Hypertens Res 2008;31(10):1865-72.

Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, et al. The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol 2007;50(13):1238-45.

Shah AM, Lam CS, Cheng S, Verma A, Desai AS, Rocha RA, et al. The relationship between renal impairment and left ventricular structure, function, and ventriculararterial interaction in hypertension. J Hypertens 2011; 29(9):1829-36.

Cerasola G, Nardi E, Mulè G, Palermo A, Cusimano P, Guarneri M, et al. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function. Nephrology (Carlton) 2010;15(2):203-10.

Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3(2):505-21.

Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012;23(10):1725-34.

Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, et al. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. J Nephrol 2012;25(5):794-801.

Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from Pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254-66.

Olivero JJ, Nguyen PT, Olivero JJ. Chronic kidney disease: a marker of cardiovascular disease. Methodist Debakey Cardiovasc J 2009;5(2):24-9.

Rodriguez-Iturbe B, Correa-Rotter R. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease. Expert Opin Pharma cother 2010;11(16):2687-98.

Zoccali C, Benedetto FA, Tripepi G, Mallanaci F, Rapisarda F, Seminara G, et al. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 2006;17 (5):1460-5.

Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36(2):286-90.

Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI17-23

McMahon LP, Roger SD, Levin A; Slimheart Investigators Group. Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol 2004;15(6):1640-7.

Downloads

Published

15-03-2024

How to Cite

1.
Leedumrongwattanakul K, Leedumrongwattanakul A. Correlation between Glomerular Infiltration Rate and Left Ventricular Mass Index in Chronic Kidney Disease Patients. J DMS [Internet]. 2024 Mar. 15 [cited 2024 Nov. 22];49(1):55-62. Available from: https://he02.tci-thaijo.org/index.php/JDMS/article/view/263580

Issue

Section

Original Article